Showing results (111-120 of 274) with videos related to
Sort By:
Pageof 28
The Oncologist|October 16, 2016
Survival Outcomes in Asymptomatic Patients With Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography ImagingKhurum Khan, Avani Athauda, Katharine Aitken, et al.European Journal of Cancer (Oxford, England : 1990)|September 23, 2019
Influence of sex on chemotherapy efficacy and toxicity in oesophagogastric cancer: A pooled analysis of four randomised trialsMichael Davidson, Anna Dorothea Wagner, Kyriakos Kouvelakis, et al.Haematologica|February 14, 2007
Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experienceHendrik-Tobias Arkenau, Geoff Chong, David Cunningham, et al.Investigational New Drugs|March 5, 2013
An open-label study of the safety and tolerability of pazopanib in combination with FOLFOX6 or CapeOx in patients with colorectal cancerJoanne Brady, Pippa Corrie, Ian Chau, et al.Leukemia & Lymphoma|November 5, 2021
Risk of thyroid disorders in adult and childhood Hodgkin lymphoma survivors 40 years after treatmentAislinn Macklin-Doherty, Michael Jones, Penny Coulson, et al.BMC Cancer|April 10, 2024
Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 studyElena Elez, Antonio Cubillo, Pilar Garcia Alfonso, et al.BMC Cancer|January 22, 2015
Prognostic factors and treatment outcomes in patients with Small Bowel Adenocarcinoma (SBA): the Royal Marsden Hospital (RMH) experienceKhurum Khan, Clare Peckitt, Francesco Sclafani, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2004
A randomized trial comparing defined-duration with continuous irinotecan until disease progression in fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancerRohit Lal, James Dickson, David Cunningham, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2002
Multicenter randomized phase III trial comparing protracted venous infusion (PVI) fluorouracil (5-FU) with PVI 5-FU plus mitomycin in inoperable pancreatic cancerNick Maisey, Ian Chau, David Cunningham, et al.Expert Review of Anticancer Therapy|August 19, 2017
Current challenges in optimizing systemic therapy for patients with pancreatic cancer: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international facultyEva Segelov, Florian Lordick, David Goldstein, et al.Pageof 28